Xtl Biopharmaceuticals (XTLB) Interest Coverage Ratio Growth (1y) (2010 - 2024)
Xtl Biopharmaceuticals (XTLB) Interest Coverage Ratio Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Xtl Biopharmaceuticals | 2.60 Bn | 2.60 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 39.85% |
| Jun 30, 2024 | 1,064.32% |
| Mar 31, 2024 | -208.94% |
| Sep 30, 2023 | 93.68% |
| Jun 30, 2023 | -72.26% |
| Mar 31, 2023 | -63.71% |
| Dec 31, 2018 | -6.35% |
| Sep 30, 2018 | 317,732.63% |
| Jun 30, 2018 | -625.81% |
| Mar 31, 2018 | -6,831.19% |
| Dec 31, 2017 | 96.52% |
| Sep 30, 2017 | -99.95% |
| Jun 30, 2017 | 97.28% |
| Mar 31, 2017 | -99.84% |
| Dec 31, 2016 | -422.62% |
| Sep 30, 2016 | 4,418.18% |
| Jun 30, 2016 | -252.30% |
| Mar 31, 2016 | 1,380.85% |
| Dec 31, 2015 | -198.74% |
| Sep 30, 2015 | -223.05% |